Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO Specialty Renal Products
-
Stock Symbol
-
NEPH on Nasdaq
There are no Buy or Sell transactions made by Daron Evans since 12/17/2023
Holdings reported by Daron Evans for Nephros Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
134K |
$296K |
$2.20 |
May 24, 2021 |
Direct |
|
|
| Common Stock |
8.95K |
$19.7K |
$2.20 |
May 27, 2021 |
By UTMA #1 |
|
|
| Common Stock |
8.67K |
$19.1K |
$2.20 |
May 27, 2021 |
By UTMA #2 |
|
|
| Common Stock |
6.11K |
$13.5K |
$2.20 |
May 24, 2021 |
By PoC Capital, LLC |
|
|
| Common Stock |
888 |
$1.96K |
$2.20 |
May 24, 2021 |
By UTMA #3 |
|
|
| Common Stock |
888 |
$1.96K |
$2.20 |
May 24, 2021 |
By UTMA #4 |
|
|
| Stock Option (Right to Buy) |
20K |
|
|
May 24, 2021 |
Direct |
Common Stock |
20K |
| Common Stock Warrants (Right to Buy) |
0 |
|
|
May 24, 2021 |
By UTMA #1 |
Common Stock |
|
| Common Stock Warrants (Right to Buy) |
0 |
|
|
May 24, 2021 |
By UTMA #2 |
Common Stock |
|
Transactions reported by Daron Evans for Nephros Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.